AstraZeneca is presenting research at the ESC Congress regarding uncontrolled hypertension and interconnected disease.
Public source
Publisher name
Public post
Sometimes it's the simplest facts that stick with you: Millions of people living with hypertension still don't reach recommended blood pressure goals despite the treatme…
Company
AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 10,001+ employees
About AstraZeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
See moreLatest activity
Latest activity from AstraZeneca
141 signals
Presence & Recognition
AstraZeneca leaders share their vision for how continued scientific progress could transform what is possible by 2040 as they head into WCLC 2026
Presence & Recognition
AstraZeneca is reflecting on the future of lung cancer care ahead of WCLC 2026.
Research & Knowledge
AstraZeneca and partner Amgen announced positive high-level Phase III results from the DeLLphi-305 trial in extensive-stage small cell lung cancer.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Pfizer
Pfizer announced that ESC Congress 2026 brought vital updates on ATTR-CM therapeutics and management.
Presence & Recognition
Bristol Myers Squibb
Bristol Myers Squibb shared new research and scientific perspectives at the ESC Congress.
Presence & Recognition
Novartis
Novartis participated in this year's ESC Congress to work alongside clinicians and researchers to make preventable cardiovascular deaths a thing of the past.
Presence & Recognition
GSK